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Abstract
Background: The parameters RN (Newtonian resistance), G (tissue damping), and H (tissue elastance) of the constant phase
model of respiratory mechanics provide information concerning the site of altered mechanical properties of the lung. The
aims of this study were to compare the site of allergic airway narrowing implied from respiratory mechanics to a direct
assessment by morphometry and to evaluate the effects of exogenous surfactant administration on the site and magnitude
of airway narrowing.
Methods: We induced airway narrowing by ovalbumin sensitization and challenge and we tested the effects of a natural
surfactant lacking surfactant proteins A and D (InfasurfH) on airway responses. Sensitized, mechanically ventilated Brown
Norway rats underwent an aerosol challenge with 5% ovalbumin or vehicle. Other animals received nebulized surfactant
prior to challenge. Three or 20 minutes after ovalbumin challenge, airway luminal areas were assessed on snap-frozen lungs
by morphometry.
Results: At 3 minutes, RN and G detected large airway narrowing whereas at 20 minutes G and H detected small airway
narrowing. Surfactant inhibited RN at the peak of the early allergic response and ovalbumin-induced increase in
bronchoalveolar lavage fluid cysteinyl leukotrienes and amphiregulin but not IgE-induced mast cell activation in vitro.
Conclusion: Allergen challenge triggers the rapid onset of large airway narrowing, detected by RN and G, and subsequent
peripheral airway narrowing detected by G and H. Surfactant inhibits airway narrowing and reduces mast cell-derived
mediators.
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Introduction
The constant phase model of respiratory mechanics has been
proposed for the partitioning of pulmonary responses to the
airways and tissues [1,2]. Changes in mechanics directly
attributable to narrowing of the conducting airways is detected
by RN and changes in tissue viscous resistance (tissue viscance or
tissue damping) are detected by the G parameter [1]. Tissue
damping increases with heterogeneity of bronchoconstriction and
hyperinflation [3,4]. Hyperinflation and inhomogeneity of venti-
lation distribution also contribute to increases in tissue elastance
(H parameter) [5]. Since airway resistance is predominantly
contributed by the larger conducting airways, the constant phase
model parameters may partition the airway responses into those
related to the large airways (RN) and to the peripheral lung (G and
H) [2]. The site of airway narrowing following methacholine or
allergen-induced bronchoconstriction may be directly assessed by
snap-freezing lungs and performing morphometric measurements
[6].
Allergen challenge of sensitized subjects may result in early
and late responses [1]. The early response occurs within minutes
after allergen exposure and results from mast cell degranulation
and the release of preformed biogenic amines including
histamine and serotonin and the de novo synthesis of cysteinyl
leukotrienes (CysLTs) [7,8]. These mediators also cause a
vascular leak into the airways [9,10]. Microvascular leak of
proteins as well as surfactant phospholipid changes such as that
occurring during allergen-induced airway reactions may disrupt
surfactant function [11,12] and serve as an additional mechanism
for airway narrowing following allergen challenge. Surfactant
administration may be beneficial in restoring surfactant activity
[13] and we reasoned it would preferentially reduce peripheral
airway narrowing following allergen challenge. A previous study
of allergen challenge of the sensitized rat by the inhalational
route has shown that alterations in respiratory mechanics reflect
a mixed large airway and peripheral lung response [14],
suggesting that this model was suited to addressing the effects
of surfactant.
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29381The first objective of the current study was to compare the site
of airway narrowing as determined by the constant phase model
and by morphometry during the early allergic response (EAR).
The second objective was to assess the potential modulation of
changes in airway mechanics following Ova or serotonin-induced
bronchoconstriction by the administration of surfactant. To
examine if surfactant might inhibit the allergic response itself, we
also assessed the mast cell mediators, CysLTs and amphiregulin, in
bronchoalveolar lavage fluid immediately after the peak of the
EAR after Ova challenge. Additionally we examined the effects of
surfactant on Ova-triggered mast cell activation ex vivo.
Methods
Ethics Statement
The study protocol was approved by the Animal Care
Committee of McGill University.
Animals and sensitization to ovalbumin
Male Brown Norway (BN) rats, 6–8 weeks old and weighing
160–180 g (SsN substrain) (Harlan/UK), were sensitized subcuta-
neously with 1 mg ovalbumin (Ova) and 100 mg aluminum
hydroxide dissolved in 1 mL of phosphate buffered saline (PBS)
[15]. Concurrently, the rats were injected intraperitoneally with
2610
9 Bordetella pertussis heat-killed bacteria, an adjuvant (provided
by T. Issekutz, Dalhousie, University, Halifax, NS, Canada) [15].
Measurement of early allergic response (EAR) to
ovalbumin challenge
Fourteen days after sensitization, rats were endotracheally
intubated under light pentobarbital anesthesia and then admin-
istered an aerosol challenge for 1 minute, with either 5% Ova or
the PBS control, using an ultrasonic nebulizer. Paralysis was
induced with 1 mg/kg pancuronium bromide intraperitoneally
(Sandoz Canada Inc, QC, Canada). The animals were placed on a
heating pad and their body temperature was monitored with a
rectal thermometer. The animals were ventilated at a tidal volume
of 8 mL/kg, a breathing frequency of 90 breaths/minute and an
end-expiratory pressure of 2.5 cmH2O using a computer con-
trolled small animal ventilator ((Flexivent, Scireq, Montre ´al, QC,
Canada) up to 20 minutes after the Ova or PBS challenge.
Respiratory system mechanics were assessed every 15 seconds
using the constant phase model [16]. The latter model fits the data
to an equation that has four parameters and these are estimated by
solving the following:
Zrs f ðÞ ~RN z j|2pf|Iaw G{j|H ðÞ = 2pf ðÞ
a:
where Z is input impedance and expresses the combined effects of
resistance, compliance and inertance as a function of frequency,
RN is Newtonian resistance (frequency independent), Iaw is airway
inertance and is dominated by the mass of gas in the central
airways, and impedance of tissues is accounted for by both G and
H. G (tissue damping) is closely related to peripheral airway and
tissue resistance and reflects energy dissipation in the lung tissues, j
is an imaginary number, H is tissue elastance and reflects energy
storage in the tissues, a is 2/ptan
21(H/G) and f is respiratory
frequency.
Effects of surfactant on respiratory mechanical responses
to ovalbumin challenge
Sensitized rats were anesthetized, paralyzed and mechanically
ventilated as described above. Following a baseline recording of
mechanics, the animals were administered an ultrasonic nebuli-
zation of 200 mL of a commercially available surfactant (,7m g
phospholipids), InfasurfH (ONY, Inc, Amherst, NY) or saline, for
5 minutes. This intervention was immediately followed by an Ova
or PBS challenge for 1 minute. The animals had measurements of
respiratory mechanics every 15 seconds for the subsequent
20 minutes. InfasurfH contains natural phospholipids, neutral
lipids and hydrophobic surfactant associated proteins in 0.9%
sodium chloride including surfactant protein (SP)-B [17,18].
According to the manufacturer, InfasurfH does not contain
surfactant proteins A and D, collectins that have been shown to
have immunomodulatory effects (as reviewed in [19–21]).
Assessment of airway narrowing by morphometry
Separate groups of animals underwent sensitization and
challenge with Ova as described above but were sacrificed
,3 minutes or at 20 minutes following challenge and the lungs
were snap-frozen for morphometric assessment (n=426). A
constant pressure of 4 cmH2O was applied during freezing so as
to fix the lungs at a lung volume within the range of tidal breathing
during fixation [6,22]. The chest cavity was rapidly opened and
liquid nitrogen was poured covering the lungs [6]. The lungs were
removed and immersed in Carnoy’s solution and stored at 280uC
overnight [6]. The following day the lungs were processed in a
series of modified Carnoy’s solutions and the tissue was paraffin-
embedded [6].
Histological sections (5 mm) were cut from mid-sagittal and
para-hilar regions of the lung and were stained with hematoxylin
and eosin. The lumen area was traced for at least 10 airways per
animal and the ideal lumen area was calculated from the internal
basement perimeter (PBM) on the assumption that the fully
dilated airway is a circle. All airways in the whole lung section
whose aspect ratio (maximal to minimal internal diameter) was
less than 2, were included in the analyses. The median PBM of
the airways studied after a single challenge was 0.89 mm. To
assess airway narrowing heterogeneity, the coefficient of
variation of the airway lumina was calculated for airways
.0.89 mm and for those airways ,0.89 mm. Lung sections
from a separate group of Ova-sensitized animals were stained
with toluidine blue for the assessment of mast cell distribution
(n=8) and smooth muscle (SM) a-actin for airway smooth
muscle (ASM) assessment (n=6).
Assessment of cysteinyl leukotriene and amphiregulin
concentrations in the bronchoalveolar lavage (BAL) fluid
at the peaks of EAR
Separate groups of animals were used to assess the CysLTs
(n=528/group) and amphiregulin concentrations (n=729/
group) in the BAL fluid following Ova or PBS challenge. Two
weeks after sensitization with Ova, the animals were anaesthetized,
paralyzed and mechanically ventilated as described above. Saline
or surfactant was administered for 5 minutes using an ultrasonic
nebulizer followed by either an Ova or PBS challenge. At peak
EAR, the animals were sacrificed and underwent BAL. BAL was
performed using sterile 16PBS, which was administered into the
lungs and then drawn out with a syringe. The first 5 mL of BAL
fluid was stored at 280uC for further analysis. Amphiregulin levels
were assayed using the human Amphiregulin kit (R&D Systems,
Minneopolis, MN). The lower limit of detection for amphiregulin
is 15.6 pg/mL. For the CysLT measurement, samples were
extracted using Sep-Pak cartridges (Waters, Milford, MA) and
subsequently analyzed after 8-fold dilution using the CysLT
Express EIA Kit (Cayman Chemical Company, MI, USA). The
Site of Allergic Airway Narrowing and Surfactant
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20 pg/mL.
Assessment of serotonin-induced bronchoconstriction in
the presence of surfactant
Serotonin (serotonin hydrochloride, 5-HT, Sigma-Aldrich
Canada Ltd., Oakville, ON, Canada) was used to induce the
bronchoconstriction. 5-HT (30 mg/mL) was nebulized to non-
sensitized, anesthetized, and paralyzed BN rats for 20 seconds
(n=8) using the small animal ventilator (Flexivent) [9]. Another
group of animals (n=8) was administered nebulized surfactant
(InfasurfH, ONY, Inc., NY, US) for 5 minutes prior to the 5-HT
administration. Subsequently, the bronchoconstrictive response
was assessed using the constant phase model over 20 minutes.
Assessment of intracellular calcium release in RBL-2H3
mast cell line
The RBL (rat basophilic leukemia)-2H3 mast cell line
(American Type Culture Collection, USA) was maintained in
Dulbecco’s modified Eagle medium (DMEM) with 20% fetal
bovine serum and antibiotics (penicillin-streptomycin-amphoteri-
cin B) Cells were plated on glass coverslips until they reached
confluence. About 4 hours prior to measurements, serum was
removed and replaced by PIPES buffer containing 140 mM NaCl,
5 mM KCl, 0.6 mM MgCl2, 1.0 mM CaCl2, 5.5 mM glucose
and 10 mM piperazine-N-N9-bis (2-ethanesulfonic acid); pH 7.4).
For the experiments performed in the absence of external calcium,
PIPES–EGTA buffer (1.0 mM EGTA) was used. Thirty minutes
prior to each measurement, RBL-2H3 cells were loaded with
5 mM Fura-2 AM (Molecular Probes, Eugene, OR), mounted in a
Leiden chamber (Medical Systems, Greenville, NY) and viewed
under the 406oil immersion objective on an inverted microscope
(Olympus, Tokyo, Japan). Five minutes prior to measurements,
10% of either control (saline) or natural exogenous surfactant was
added to the medium. Calcium (Ca
2+) signaling was triggered by
addition of Ova and serum from Ova-sensitized and challenged
rat solution (final concentration: 50 mg/ml Ova, 5% serum)
premixed 30 minutes prior to the challenge. Fura-2 was
alternatively excited at 340 nm and 380 nm with a PTI Deltascan
1 dual monochromator illuminator (Photon Technology Interna-
tional, Princeton, NJ). Additionally, fluorescent properties of the
FURA-2 were verified in vitro by performing excitation-scan
fluorescence measurements in presence of 0 and 39 mMC a
2+ with
surfactant or saline. Ratios (340/380) were calculated. Rmax and
Rmin were calculated in the cell line in response to ionomycin
(10 mM) in PIPES and PIPES- EGTA buffer respectively.
Fluorescent ratios were converted into Ca
2+ concentration using
the formula of Grynkiewicz (10).
Statistical analysis
Data are presented as mean+SEM. The statistical analysis was
performed using GraphPad Prism, version 5 (GraphPad Software
Inc., San Diego, CA) as well as SAS v. 9.2 (Cary, NC). Paired
means were compared using two-tailed t-tests. Linear regression
was performed using the method of least squares. Comparison of
morphometric data between the Ova and PBS-challenged animals
was assessed using a linear mixed model estimated via restricted
maximum likelihood with the independent variables being size,
Ova and interaction between Ova and size and dependent
variable being predicted luminal ratio. At 20 minutes, a term for
the square of size was also included. This model adjusts for
correlation between airways from the same rats by including a
random intercept.
For the mechanical parameters of the total respiratory resistance
of the surfactant groups, a one-way ANOVA and Newman-Keuls
test was performed on data at 3 and 20 minutes. For the
corresponding morphometry at 3 minutes, a one-way ANOVA
and Bonferroni correction was used for comparisons of interest. A
one-way ANOVA and Newman-Keuls post hoc test was performed
on the data for CysLTs and amphiregulin. To assess mechanical
parameters of the response in the 5-HT and surfactant + 5-HT
groups, two-tailed t-tests were performed for data immediately after
the 5-HT administration and at 5, 10, 15 and 20 minutes.
Results
Early allergic response: Constant phase parameters
At 3 minutes after Ova challenge, RN and G increased
significantly compared to baseline (p,0.05, n=8210, figure 1
A, B). RN declined subsequently so that by 20 minutes after
challenge it was no longer significantly increased. However the
elevation in G persisted (p,0.01, figure 1A, B). H was not
increased at 3 minutes but was significantly increased at
20 minutes (p,0.05, figure 1C). Normalized parameters for the
Ova-challenged animals illustrate the relative progression in the
individual parameters over 20 minutes (figure 1D).
At 3 minutes, there was no significant difference in RN/G
compared to baseline suggesting that these parameters are coupled
(figure 2A). However, RN/H was significantly higher than controls
at 3 minutes (p,0.05, figure 2B). Similarly, G/H or hysteresivity,
the ratio of energy dissipation to energy conservation, was higher at
3 minutes in Ova-challenged animals compared to controls
(p,0.05, figure 2C) butnot different amongstgroups at 20 minutes.
Airway narrowing: morphometric assessment
Airway narrowing was assessed from the ratio of the lumen area
to the ideal lumen, the area corresponding to the airway
circumference calculated for a perfect circle. The median airway
PBM of all the airways assessed was 0.89 mm. Three minutes after
Ova challenge, only the airways $0.89 mm were relatively more
constricted than the comparable airways in controls (p,0.05,
n=526, figure 3A). At 20 minutes, the airway narrowing in the
Ova-challenged animals was greater in the airways with a
PBM,0.89 mm (p,0.01) and larger airways were no longer
significantly narrowed (n=526, figure 3B).
We tested the sensitivity of the statistical significance in
differences in larger airway narrowing induced by Ova challenge
to the choice of cut-off of airway size. The minimum cut-off which
gave significance at 3 minutes was 0.86 mm, corresponding
closely to the median airway size, 0.89 mm in PBM. At 3 minutes
in the Ova group, the luminal ratio declined as airway size
increased as did the difference in luminal ratio between the Ova
and PBS groups (figure 3C). However, at 20 minutes, the
difference in luminal ratio between Ova and PBS diminished as
airway size increased (figure 3D). At .1.77 PBM, the luminal ratio
difference between Ova and PBS groups was no longer
significantly different.
Heterogeneity of airway narrowing
Figure 4A is an illustration of hematoxylin and eosin staining in
an airway from a PBS and Ova-challenged animal respectively. At
3 minutes after Ova or PBS challenges there were no significant
differences in the coefficients of variation of luminal areas amongst
groups (n=426, figure 4B). In comparison at 20 minutes, the
smaller airways (,0.89 mm) showed significantly greater hetero-
geneity of airway narrowing after Ova challenge compared to the
controls (p,0.05, n=6) while there was a trend (p=0.09) for the
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airway narrowing compared to their respective controls (figure 4C).
Potential determinants of the distribution of airway
narrowing during the EAR
We wished to explore some of the possible determinants of
differences in the distribution of airway narrowing from large to
small airways. There were no clear differences in the distribution
of the mast cells in non-Ova-challenged animals between airways
of PBM $0.89 mm and ,0.89 mm (figure S1A).
ASM mass in Ova-sensitized, non-challenged animals was
normalized for the square of the PBM to correct for airway size.
There were no differences in the normalized SM as a function of
airway size (figure S1B).
Figure 1. RN, G, and H over the 20 minute period following aerosol challenge with PBS or Ova and normalized constant phase
parameters over time in Ova-challenged animals. (A) RN and (B) G are significantly different following Ova challenge than their respective
controls (n=628/group) at 3 minutes while (B, C) G and H are markedly higher than controls at 20 minutes. (D) Illustration of normalized parameters
for the Ova-challenged animals (*p,0.05, **p,0.01).
doi:10.1371/journal.pone.0029381.g001
Figure 2. RN/G, RN/H and G/H over the 20 minute period following aerosol challenge with PBS or Ova. While there were no differences
in (A) RN/G, (B) RN/H and (C) G/H were significantly elevated at 3 minutes after Ova challenge (n=628/group). At 20 minutes there were no
significant changes (*p,0.05).
doi:10.1371/journal.pone.0029381.g002
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airway narrowing as assessed by morphometry during
the EAR
At 3 minutes after challenge there was a significant increase in
RN from baseline in Ova- challenged animals which was
decreased by exogenous surfactant administration (p,0.05,
figure 5A). The G parameter in the Ova-challenged animals
increased significantly at 3 minutes (p,0.001, figure 5B) and the
increase in G was prevented by pre-treatment with exogenous
surfactant (p,0.05, figure 5B), while there were no changes in
the H parameter (figure 5C). In both RN and G, there was also
a marked difference between the surfactant-administered,
Ova-challenged and the saline administered, Ova-challenged
groups (p,0.05, figure 5A and p,0.01 figure 5B respectively).
By 20 minutes after Ova challenge RN, G and H parameters
were not significantly different from baseline values (data not
shown).
In the Ova-challenged animals at the peak of EAR, the airways
.0.89 mm PBM were significantly bronchoconstricted (p,0.05,
figure 5D). The morphometric data for the airways .0.89 mm
showed a lesser degree of airway narrowing after Ova challenge in
animals pre-treated with surfactant. There were no significant
differences in the Ova-challenged animals compared to controls in
the airways ,0.89 mm (figure 5D). Given the lack of changes in
mechanical parameters at 20 minutes, morphometry was not
performed at this time point.
Effects of surfactant on inflammatory mediators
(cysteinyl leukotrienes and amphiregulin) in the BAL fluid
Assessment of the concentration of total CysLTs from the
B A La tt h ep e a ko ft h eE A Ri nt h es t u d yg r o u p sr e v e a l e da n
elevated concentration in the Ova-challenged animals com-
pared to controls (p,0.05, n=527, figure 6A). This increase in
CysLTs was abrogated in animals that received exogenous
administration of surfactant (p,0.05, n=528, figure 6A).
Similarly, surfactant prevented the increase in amphiregulin
that was induced by Ova-exposure during peak EAR (p,0.05,
n=729, figure 6B).
Figure 3. Airway Narrowing Morphometry at 3 and 20 minutes after aerosol challenge with PBS or Ova. Statistics were performed using
the median airway size to assign airways .0.89 mm as medium/large airways and ,0.89 mm as small airways.Comparison of morphometric data
between the Ova and PBS-challenged animals was performed with a linear mixed model. (A) At 3 minutes, only larger airways in Ova compared to
PBS were significantly different (C) 0.86 PBM was the minimum cut-off to observe such differences. (B) At 20 minutes, only the smaller airways
indicated significant differences between the treatment groups and (D) with increasing airway size, the luminal ratio difference between the
treatment groups diminished. (n=526, *p,0.05,**p,0.01).
doi:10.1371/journal.pone.0029381.g003
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mediated bronchoconstriction in the presence of
surfactant
Serotonin was administered at a high dose to induce
bronchoconstriction with a time course not dissimilar to the
EAR. Following serotonin RN, G and H increased. Surfactant
reduced the change in RN at both the peak of the response, and at
5, 10 and 15 minutes into the response (n=7, p,0.01, p,0.05,
figure 6C). There was a trend for the reduction of G at 5 and
10 minutes (p=0.08 and 0.065 respectively, figure 6D) while H
was not significantly altered at any time point (data not shown).
Effects of surfactant on RBL cell activation by Ova
RBL cells were used to model the effects of surfactant on Ova-
mediated mast cell activation. First we tested the effects of
surfactant on the detection of calcium in a cell-free FURA-2
solution. As illustrated in figure S2A for Ca
2+ concentrations of 0
and 39 mM, we observed that the fluorescence of FURA-2 was
altered with surfactant (n=526, figure S2B) and we applied a
correction to the calibration to account for the signals in the RBL
cells in the presence of surfactant. Figure 7A illustrates mast cell
responses upon addition of serum and Ova. There were no
differences in the baseline intracellular calcium concentrations
with and without surfactant (n=526, figure 7B). Neither the peak
nor the plateau response in calcium were significantly affected by
the presence of surfactant (n=526, figure 7 C,D).
Discussion
Ova exposure triggered a significant EAR in sensitized animals
as determined from changes in respiratory mechanical properties
of the respiratory system. The peak of the EAR occurred at
,3 minutes after the challenge at which time both of the
parameters RN and G of the constant phase model were elevated.
By 20 minutes, RN was no longer significantly elevated but G and
H were. Narrowing of the large airways (.median size) assessed by
morphometry was present at 3 minutes after challenge and had
resolved by 20 minutes whereas the narrowing of the smaller
airways (,median size) was not evident at 3 minutes but was
present at 20 minutes. Surfactant administered prior to allergen
challenge inhibited the changes in mechanical parameters
reflecting large airway constriction at 3 minutes after challenge.
Surfactant inhibited the release of the mast cell-derived inflam-
matory mediators, cysteinyl leukotrienes and amphiregulin, at the
EAR peak. Ex vivo, surfactant failed to inhibit Ova-induced
calcium release from RBL cells, indicating that the amelioration of
airway narrowing by surfactant is more likely attributable to
indirect effects on mast cells.
Following Ova challenge, RN and G rose quickly and
synchronously whereas the changes in H lagged in time. The
changes in RN were transient whereas changes in G persisted over
the 20 minute period of observation. RN/G was not significantly
elevated at peak EAR suggesting that these parameters may share
common determinants, namely narrowing of the airways larger
than the median value or that they may reflect simultaneous effects
on different regions within the airway tree and lung parenchyma.
The change in RN is usually attributed to airway resistance and G
to tissue damping [1,23]. The elevation in G at a time when RN
had partially recovered is consistent with the idea that the factors
contributing to RN and G are not identical. In contrast, RN/H and
G/H were significantly different at peak EAR, also suggesting that
H is determined by changes in the peripheral lung tissues and
beyond the airways captured by changes in RN and G. In order to
assess the contributions of the narrowing of airways of different
sizes to the parameters of the constant phase model, we snap-froze
lungs following allergen challenge at a transpulmonary pressure
that fixed lung volume in the tidal breathing range, using
previously published methodology [22]. We divided airways into
Figure 4. Airway narrowing heterogeneity at 3 min and 20 min after aerosol challenge with PBS or Ova. (A) Illustration of
bronchoconstriction in PBS and Ova-challenged animals (Scaling bar=100 mm). (B) While there were no differences to report at 3 minutes (n=526),
(C) airway narrowing heterogeneity was greater in the Ova-challenged animals compared to controls at 20 minutes (n=426, *p,0.05).
doi:10.1371/journal.pone.0029381.g004
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(0.89 mm internal perimeter) in order to relate morphometric
measurements of airway narrowing to the constant phase
parameters. The morphometric data showed narrowing of the
larger airways at the peak EAR and recovery by 20 minutes. The
converse was observed for smaller airways that were narrowed
significantly at 20 minutes but not at 3 minutes after challenge.
These data are in concordance with the interpretation offered for
the parameters of the constant phase model, although it does
appear that the G parameter is sensitive to both large and small
airway narrowing.
The heterogeneity of airway narrowing seems likely to be
dependent on the fact that airway narrowing was induced by
aerosol challenge [22] although a substantial contribution from
local mechanisms and not solely non-uniform agonist delivery has
also been suggested [24]. There were no differences in
heterogeneity of airway narrowing at 3 minutes after challenge
amongst any of the groups. By 20 minutes after Ova challenge, the
heterogeneity of airway narrowing markedly increased in the
smaller airways and showed a trend for increase in the larger
airways. The coefficient of variation of the airway luminal sizes in
the PBS-challenged group was higher at 3 minutes than at
20 minutes suggesting that there was a response in the larger
airways to PBS, albeit resulting in a much smaller observable effect
on respiratory system mechanics. The heterogeneity of constricted
airways may be analyzed via direct visualization by morphometric
analysis on frozen lungs [25], by hyperpolarized 3-helium dynamic
MRI [26], high-resolution computerized tomography [27–29],
synchrotron radiation computerized tomography [30], mechanical
measurements such as the alveolar capsule technique [31] and by
forced oscillation and model fitting to whole lung impedance data
[32,33]. The heterogeneity of small airway narrowing observed for
Ova-challenged animals correlated with the G and H parameters.
We explored several of the important potential determinants of
the site and magnitude of Ova- induced airway narrowing such as
mast cell density and ASM mass. We found no clear differences in
mast cell distribution across airways of increasing size and no
significant airway size dependence of SM mass. There are several
factors which should favour a greater narrowing of the smaller
airways for an equivalent allergen challenge. Firstly, the decrease
in airway radius should reduce the wall tension required to create
a given transmural pressure, based on the Laplace relationship
[34]. For similar reasons, surface tension within the small airways
should favour airway narrowing ([35] and figure S3) and the effect
Figure 5. Surfactant effects on the constant phase parameters of AHR and corresponding morphometric assessments. The following
groups were compared: PBS (n=10), Ova (n=11), Surf-PBS (n=6), and Surf-Ova (n=12). (A) RN and (B) G at 3 minutes were inhibited by exogenous,
natural surfactant administration, (C) H at 3 minutes, (D) The larger airways are bronchoconstricted as assessed by morphometry but the surfactant
effects did not reach significance (n=427, *p,0.05).
doi:10.1371/journal.pone.0029381.g005
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surfactant properties by the microvascular leak of protein that has
been shown to occur during the early allergic response [9]. We
speculate that, as been previously suggested, the more sustained
abnormality in peripheral lung mechanics may be attributable to
airway closure [36], favored by high surface tension and the
development of fluid menisci within some of the small airways.
The surface tension of the fluid in the lungs in vivo has been
estimated to be between 5 and 30 dynes/cm or mN/m [37].
Forty-eight hours after antigen challenge, there is reportedly a
dysfunction in pulmonary surfactant [38]. It was later reported
that in asthmatic humans, phospholipid alteration in surfactant,
particularly in phosphatidylglycerol, occurs after antigen challenge
[12]. Furthermore, in stable asthmatic individuals, dipalmitoyl
phosphatidylcholine, the primary phospholipid found in surfactant
is reduced in sputum but not BAL surfactant [39]. Small airways
are most at risk of closure and an intervention to decrease surface
tension may decrease the risk of airway closure. In small animals
the distribution of the surfactant-producing Clara cells throughout
the airways suggests that surfactant may have such a role even in
larger sized airways in small animals [40]. In order to explore the
plausibility of disruption of surfactant function within the airways
Figure 6. Mast cell–derived mediators in BAL fluid and in vivo assessment of EAR responses with serotonin-mediated
bronchoconstriction in the presence of surfactant BAL was performed at 3 minutes after PBS or Ova challenge and mediators
were measured by EIA or ELISA kits. (A) Cysteinyl leukotrienes (n=528/group) and (B) amphiregulin levels (n=729/group) (*p,0.05), (C)
Serotonin-induced bronchoconstriction is inhibited by pre-treatment with surfactant, as observed in RN at the peak response as well as at 5, 10, and
15 minutes after allergen challenge (n=7, *p,0.05, **p,0.01). (D) At 5 minutes into the response, there is a trend for the inhibition of the G
parameter by surfactant (p=0.08) as well as at 10 minutes (p=0.065).
doi:10.1371/journal.pone.0029381.g006
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might be expected as a result of surface tension as a function of
airway size using the Laplace relation (figure S3). Based on our
experimental data, surfactant had protective effects in inhibiting
airway obstruction. We had postulated this effect would be most
evident in the peripheral airways as this is the site where surfactant
is endogenously more abundant and has the greatest effect on
transmural pressure. However, the inhibition of the peak EAR, as
well as the reduction of bronchoconstriction of the larger airways,
indicated that surfactant was protective in larger airways. The
aerosolization of saline for 5 minutes prior to Ova challenge also
appears to have modified airway responses, as the G and H
parameters in these animals at 20 minutes post Ova challenge
were not statistically significantly different from baseline values, in
contrast to the animals that did not receive any aerosolization
prior to allergen challenge.
Synthetic surfactant has been described to inhibit early allergic
airway responses in human subjects, presumably related to effects
on surface tension. Collectins have been associated with the
inhibition of various mediators including the IgE-mediated
degranulation of mast cells [41]. However surfactant proteins A
and D are not present in the surfactant preparation that we used. A
protective role of inhaled synthetic, protein-free, phospholipid-
based surfactant in the early allergen-induced response in humans
has also been described [42]. To address the possibility that the
surfactant we employed, lacking immunomodulatory proteins,
might have a role in modulating inflammatory mediators, we
assessed the concentrations of CysLTs in the BAL in BN rats
immediately after the EAR peak was reached. CysLTs were
significantly inhibited by exogenous surfactant administration. We
observed similar results with amphiregulin. Amphiregulin, an
epidermal growth factor receptor ligand, is reported to be present
in 70% of the mast cells from human asthmatic airways and human
cord blood-derived mast cells (CBMCs) secrete amphiregulin upon
IgE crosslinking [43]. It is released by epithelial and mast cells and
could potentially be important in the EAR as it has beenreported to
be elevated after an acute asthma attack in humans [44].
We examined the effects of this surfactant preparation on the
activation of RBL-2H3 cells, a frequently used model for the mast
cell. The effects of surfactant appear to be indirect on the mast
cells since activation by Ova and sensitized serum ex vivo was not
reduced by treatment with surfactant. However bronchoconstric-
tion by mechanical effects per se does not lead to release of mast cell
mediators [45] and it is therefore not clear how a reduction in
surface tension per se may have reduced mediator release.
Surfactant also reduced the serotonin-induced large airway
narrowing, indicating that the effects of mediators released by
mast cells were also likely attenuated.
In summary, ovalbumin exposure induced a significant EAR, in
which the peak of the response occurred as early as ,3 minutes
after the challenge. Mechanical assessments and morphometry on
frozen tissues indicated that the narrowing of the large airways
occurred transiently and resolved quickly whereas the peripheral
airway narrowing was more persistent. Changes in RN appear to
reflect narrowing of airways greater than the median-sized airway
whereas G is affected by airway narrowing in airways that are
larger or smaller than the median-sized airway. Exogenous
surfactant administration decreased the peak RN and G and
morphometric large airway narrowing in Ova-challenged animals,
attributable to inhibition of mast cell mediator release and
attenuation of the bronchoconstriction induced by mediators that
are released.
Supporting Information
Figure S1 Possible structural determinants of the site of
the early airway response; mast cells, ASM in Ova-
Figure 7. Effects of surfactant on RBL cell activation by Ova. (A) Images demonstrating Ca
2+ release in mast cells, upon addition of serum and
Ova. (B) There were no differences in the baseline values of the calcium with and without surfactant (n=526). (C) The peak increase in calcium
(n=526) and the (D) subsequent plateau were not significantly attenuated by prior treatment with surfactant (n=526).
doi:10.1371/journal.pone.0029381.g007
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PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e29381sensitized but unchallenged animals. (A) There was no
relationship between airway size and the density of mast cells
(n=8). (B) The size corrected area of ASM was not different in
larger (.0.89 mm PBM) compared to smaller airways (,0.89 mm
PBM) (n=6).
(TIF)
Figure S2 Effects of surfactant on RBL cell activation by
Ova. (A) Examples of responses at 0 and 39 mM, respectively, in a
cell-free mix. (B) The fluorescence of FURA-2 was altered with
surfactant (n=526, *p,0.05).
(TIF)
Figure S3 Possible determinants of early airway re-
sponse; surface tension. We calculated the transmural
pressure that might be required to overcome surface tension as a
function of airway size using the Laplace relation: P=0.0102Nc/r
where P is transmural pressure in cmH20, c is surface tension (ST)
in dynes/cm, r is airway radius in mm and the factor of 0.0102
converts from Pa to cmH20. The vertical line is indicative of ST
contributing to transmural pressure at the mean PBM (0.89 mm).
The ST of water is 70 dynes/cm while the ST of fluid in the lining
of the lung is between 5–30 dynes/cm.
(TIF)
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